Skip to content

Axol Bioscience Ltd. vs REPROCELL

Axol Bioscience Ltd. logo

Axol Bioscience Ltd.

Better Human Disease Models

49 employees · est. 2013 · Cambridge, United Kingdom

VS
REPROCELL logo

REPROCELL

Better Translating Discoveries into Therapies

58 employees · est. 2003 · Yokohama, Japan

REPROCELL is the older company (2013 vs 2003); REPROCELL is the larger of the two.

Side-by-Side Comparison

Axol Bioscience Ltd. REPROCELL
Founded
2013 2003 older
Headquarters
Cambridge, United Kingdom Yokohama, Japan
Employees
49 58 larger
Industry
Biopharma, Biotechnology Biotechnology
Funding Stage
Venture round Not tracked yet
Total Funding
$10.47M $1.99M
Funding Rounds
4 6
Services
Not tracked yet End-to-End Solutions for Cell Therapy, Stem Cell and Gene Editing Services, Diagnostic Development Support, Preclinical and Clinical Drug Development Support, Biospecimen and Molecular Services
Target Customers
Not tracked yet Cell Therapy Developers, Stem Cell Researchers, Diagnostic Developers, Preclinical Drug Developers, Clinical Drug Developers
Taxonomy
IPSC TechnologyDrug DiscoveryNeurodegenerative DiseasesNeuroinflammatory DiseasesCardiotoxicityIn Vitro Models +9 Stem Cell ResearchPre-Clinical Drug DevelopmentHuman Tissue AccessHuman Tissue TestingStem Cell Culture MediaIPSC Reprogramming Technologies +9
Website
axolbio.com reprocell.com
Axol Bioscience Ltd. logo

About Axol Bioscience Ltd.

Axol Bioscience Ltd. is a biotechnology startup based in the United Kingdom, specializing in iPSC technology to create advanced models for drug discovery. With a decade of experience, they supply human iPSC-derived cells and offer laboratory services to support drug discovery in neurodegenerative, n...

REPROCELL logo

About REPROCELL

REPROCELL, founded in 2003, operates at the forefront of the Biotechnology industry with a mission encapsulated by its slogan, "Better Translating Discoveries into Therapies." The company specializes in comprehensive support for stem cell research and pre-clinical drug development. Its unique offer...

Also comparing in this category

Comparing more than these two?

Get Axol Bioscience Ltd., REPROCELL and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Axol Bioscience Ltd. compare?

A PDF of Axol Bioscience Ltd. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Axol Bioscience Ltd. was founded in 2013, based in Cambridge, United Kingdom, with 49 employees. Axol Bioscience Ltd. is a biotechnology startup based in the United Kingdom, specializing in iPSC technology to create advanced models for drug discovery. With a decade of experience, they supply huma. REPROCELL was founded in 2003, based in Yokohama, Japan, with 58 employees. REPROCELL, founded in 2003, operates at the forefront of the Biotechnology industry with a mission encapsulated by its slogan, "Better Translating Discoveries into Therapies." The company specializes.
Axol Bioscience Ltd. has raised $10.47M and REPROCELL $1.99M. Latest stage: Axol Bioscience Ltd. Venture round.
Both work in Biotechnology and list stem cell research among their focus areas.

Compare Axol Bioscience Ltd. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Axol Bioscience Ltd. on 12 Sep 2024, and REPROCELL on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout